Identification of microRNAs involved in dexamethasone-induced muscle atrophy

Molecular and Cellular Biochemistry

Volumn 381, Issue 1-2, 2013, Pages 105-113

  Shen, He ^a   Liu, Teng ^a   Fu, Liangliang ^a   Zhao, Shuhong ^a   Fan, Bin ^a   Cao, Jianhua ^a   Li, Xinyun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

C2C12; Dexamethasone; MicroRNA; Muscle atrophy

Indexed keywords

DEXAMETHASONE; MICRORNA; MICRORNA 1; MICRORNA 147; MICRORNA 322; MICRORNA 351; MICRORNA 503; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; MOUSE; MUSCLE ATROPHY; MUSCLE GROWTH; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CLUSTER ANALYSIS; DEXAMETHASONE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; MICRORNAS; MUSCLE FIBERS, SKELETAL; MUSCULAR ATROPHY; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 84882684639     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1692-9     Document Type: Article

References (49)

1. Czerwinski SM, Zak R, Kurowski TT, Falduto MT, Hickson RC (1989) Myosin heavy chain turnover and glucocorticoid deterrence by exercise in muscle. J Appl Physiol 67(6):2311-2315
2. Adams GR, Caiozzo VJ, Baldwin KM (2003) Skeletal muscle unweighting: spaceflight and ground-based models. J Appl Physiol 95(6):2185-2201
3. Di Giovanni S, Molon A, Broccolini A, Melcon G, Mirabella M, Hoffman EP (2004) Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 55(2):195-206
4. Price DA, Bassendine MF, Norris SM, Golding C, Toms GL, Schmid ML, Morris CM, Burt AD, Donaldson PT (2006) Apo-lipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut 55(5):715-718
5. Sever JL, Rakusan TA, Campos JM, O'Donnell RM, Price VA (1996) HIV antibody responses in children of HIV-infected mothers. Pediatr AIDS HIV Infect 7(4):246-253
6. Miró O, Pedrol E, Cebrián M, Masanés F, Casademont J, Mall-olas J, Grau JM (1997) Skeletal muscle studies in patients with HIV-related wasting syndrome. J Neurol Sci 150(2):153-159
7. Baracos VE (2001) Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies. Cancer 92(6 Suppl):1669-1677
8. Mitch WE, Price SR (2001) Transcription factors and muscle cachexia: is there a therapeutic target? Lancet 357(9258):734-735
9. Brown M, Hasser EM (1996) Complexity of age-related change in skeletal muscle. J Gerontol A Biol Sci Med Sci 51(2):B2117-B2123
10. Tawa NE Jr, Odessey R, Goldberg AL (1997) Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest 100:197-203
11. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18:39-51
12. Murton AJ, Constantin D, Greenhaf PL (2008) The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 1782(12): 730-743
13. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ (2004) The IGF-1/PI3 K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14(3):395-403
14. Pallafacehina G, Calabria E, Serrano AL (2002) A protein kinase B-dependent andrapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 14(2):432-438
15. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI3 K/Akt/mTOR and PI3 K/Akt/GSK3 pathways. Nat Cell Biol 3(11):1009-1013
16. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119(2):285-298
17. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
18. Kim VN (2004) MicroRNA precursors in motion: exportin-5 mediates their nuclear export. Trends Cell Biol 14:156-159
19. Lee Y, Jeon K, Lee JT, Kim S, Kim VN (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21(17):4663-4670
20. Hwang HW, Mendell JT (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94(6):776-780
21. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38(2):228-233
22. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13(5):613-618
23. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100(3):416-424
24. Shen H, Zhao SH, Cao JH, Li XY, Fan B (2011) Porcine MuRF2 and MuRF3: molecular cloning, expression and association analysis with muscle production traits. Mol Biol Rep 38(8):5115-5123
25. -DDCt Method. Methods 25(4):402-408
26. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31(4):e15
27. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J (2006) TM4 microarray software suite. Methods Enzymol 411:134-193
28. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57:289-300
29. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ (2005) Real-time quantification of mi-croRNAs by stem-loop RT-PCR. Nucleic Acids Res 33(20):e179
30. Xie SS, Huang TH, Shen Y, Li XY, Zhang XX, Zhu MJ, Qin HY, Zhao SH (2010) Identification and characterization of microR-NAs from porcine skeletal muscle. Anim Genet 41(2):179-190
31. Mendell JT(2005) MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 4:1179-1184
32. Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15:563-568
33. Kloosterman WP, Plasterk RH (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11:441-450
34. Shivdasani RA (2006) MicroRNAs: regulators of gene expression and cell differentiation. Blood 108:3646-3653
35. Wiemer EA (2007) The role of microRNAs in cancer: no small matter. Eur J Cancer 43:1529-1544
36. Tan PK, Downey TJ, Spitznagel EL Jr, Xu P, Fu D, Dimitrov DS, Lempicki RA, Raaka BM, Cam MC (2003) Evaluation of gene expression measurements from commercial microarray platforms. NucleicAcids Res 31(19):5676-5684
37. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120:1046-1054
38. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, Lidov HG, Kang PB, North KN, Mitrani-Rosenbaum S et al (2007) Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 104: 17016-17021
39. Allen DL, Loh AS (2011) Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am J Physiol Cell Physiol 300(1):C124-C137
40. Sartorelli V, Fulco M (2004) Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy. Sci STKE 2004(244): re11
41. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294(5543):853-858
42. Lau NC, Lim LP, Weinstein EG, Bartel DP (2001) An abundant class of tiny RNAs with probable regulatory roles in Caeno-rhabditis elegans. Science 294(5543):858-862
43. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129(7):1401-1414
44. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V (2004) Expression profiling of mammalian microR-NAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5(3):R13
45. Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, Einav U, Gilad S, Hurban P, Karov Y et al (2005) MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res 14(12):2486-2494
46. Sarkar S, Dey BK, Dutta A (2010) MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell 21(13):2138-2149
47. Shan ZX, Lin QX, Fu YH, Deng CY, Zhou ZL, Zhu JN, Liu XY, Zhang YY, Li Y, Lin SG et al (2009) Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun 81(4):597-601
48. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ et al (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3(11):1014-1019
49. Ren H, Yin P, Duan C (2008) IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop. J Cell Biol 182(5):979-991